Squarepoint’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-92,939
| Closed | -$66.9K | – | 3165 |
|
|
2025
Q1 | $66.9K | Buy |
92,939
+37,888
| +69% | +$27.3K | ﹤0.01% | 2586 |
|
|
2024
Q4 | $56.7K | Buy |
+55,051
| New | +$56.7K | ﹤0.01% | 2623 |
|
|
2024
Q2 | – | Sell |
-79,401
| Closed | -$137K | – | 2947 |
|
|
2024
Q1 | $137K | Sell |
79,401
-43,401
| -35% | -$74.7K | ﹤0.01% | 2193 |
|
|
2023
Q4 | $181K | Sell |
122,802
-6,695
| -5% | -$9.84K | ﹤0.01% | 2170 |
|
|
2023
Q3 | $157K | Buy |
129,497
+51,434
| +66% | +$62.2K | ﹤0.01% | 2175 |
|
|
2023
Q2 | $113K | Buy |
+78,063
| New | +$113K | ﹤0.01% | 2193 |
|
|
2022
Q4 | – | Sell |
-16,423
| Closed | -$33K | – | 2602 |
|
|
2022
Q3 | $33K | Buy |
+16,423
| New | +$33K | ﹤0.01% | 1981 |
|
|
2020
Q4 | – | Sell |
-14,690
| Closed | -$164K | – | 2852 |
|
|
2020
Q3 | $164K | Sell |
14,690
-14,718
| -50% | -$164K | ﹤0.01% | 2006 |
|
|
2020
Q2 | $398K | Buy |
29,408
+9,019
| +44% | +$122K | 0.01% | 1412 |
|
|
2020
Q1 | $165K | Buy |
20,389
+2,386
| +13% | +$19.3K | ﹤0.01% | 1532 |
|
|
2019
Q4 | $173K | Buy |
+18,003
| New | +$173K | ﹤0.01% | 2161 |
|
|
2019
Q2 | – | Sell |
-12,951
| Closed | -$166K | – | 2565 |
|
|
2019
Q1 | $166K | Buy |
+12,951
| New | +$166K | ﹤0.01% | 1924 |
|